OpenAlex
PricingAboutJobs
Log inGet started
Work

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

HTML

Year: 2017
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2017.02.037
Authors: Nandini Dey, Pradip De, Brian Leyland-Jones
Institutions: University of South Dakota, Avera Health
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PI3K/AKT/mTOR pathway, breast cancer, triple-negative breast cancer, basal-like breast cancer, hormone receptor-positive HER2-negative breast cancer, PI3K inhibitors, mTOR inhibitors, mTORC1, mTORC2, targeted therapy, precision medicine, drug resistance, tumor cell signaling
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2589036504
FWCI: 2.776
Cites: 170
Cited by: 247
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms